ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
Vyloy is the first and only CLDN18.2-targeted therapy approved in the United States
FDA Appoints New Head of Medical Devices
Computer-Aided Detection Colonoscopies Tied to Improved Adenoma Detection Rate
Similar average advanced colorectal neoplasia per colonoscopy seen with CADe-enhanced and conventional colonoscopy
FIT Completion, Yield Rates Similar in Those Aged 45 to 49 Versus 50 Years
For individuals aged 45 to 49 years, FIT completion slightly higher while FIT positivity slightly lower
Measures of Social Support Linked to Cancer Screening
Those who report never/rarely versus always having social support may have lowest odds of screening
People With Inflammatory Bowel Disease Face Barriers to Health Care
Barriers include access to treatment, insurance barriers, and financial issues
Researchers Find Biomarker Tied to Severity of Ulcerative Colitis
HLA-DRB1*01:03 allele linked to severe disease requiring hospitalization, major operation, systemic corticosteroid use
Gut Flora Differs in Patients With Epilepsy and Cognitive Dysfunction
Collinsella, Oscillospirales, and Ruminococcaceae have a greater impact on epilepsy with cognitive dysfunction
